GC Biopharma Receives Approval for Hunterase ICV in Japan
Predicted impact: Low
Japanese approval of Hunterase ICV, a new market for a small-scale drug approval.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.